Impel NeuroPharma, Inc. (IMPL)
IMPL has a market cap or net worth of $221.16 million. The enterprise value is $139.15 million.
The latest earnings date was Monday, November 15, 2021 before market open.
|Last Earnings Date||Nov 15, 2021|
IMPL has 23.04 million shares outstanding. The number of shares has increased by 3,300.72% in one year.
|Shares Change (YoY)||+3,300.72%|
|Shares Change (QoQ)||+42.72%|
|Owned by Insiders (%)||2.47%|
|Owned by Institutions (%)||80.14%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 7.25, with a Debt / Equity ratio of 0.39.
|Debt / Equity||0.39|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||n/a|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.12M|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-37.23%|
|50-Day Moving Average||10.54|
|200-Day Moving Average||12.42|
|Average Volume (30 Days)||728,634|
Short Selling Information
|Short % of Shares Out||2.91%|
|Short % of Float||9.93%|
|Short Ratio (days to cover)||1.62|
|Earnings Per Share (EPS)||-$7.35|
The company has $111.29 million in cash and $29.29 million in debt, giving a net cash position of $82.00 million or $3.56 per share.
|Cash & Cash Equivalents||111.29M|
|Net Cash Per Share||$3.56|
|Book Value Per Share||3.29|
|Operating Cash Flow||n/a|
|Free Cash Flow||n/a|
|FCF Per Share||n/a|
Dividends & Yields
IMPL does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|